Fig. 3From: The efficacy and safety of tislelizumab combined with gemcitabine plus cisplatin in the treatment of postoperative patients with muscle-invasive upper tract urothelial carcinomaComparison of TRAEs between TGC group and GC groupTGC: tislelizumab combined with gemcitabine plus cisplatinGC: gemcitabine plus cisplatinBack to article page